S

S&P Global Finds that Women Are on Track to Achieve Parity in Gender Representation among U.S. Corporate Leadership Roles as soon as 2030

Retrieved on: 
Thursday, August 10, 2023
Workforce, Male, Research report, S&P Global, CFA, COVID-19, Woman, Research, Doctor of Philosophy, Value investing, S, Russell, CFO, SPGI, Growth, NYSE, Female, Management, Parity

NEW YORK, Aug. 10, 2023 /PRNewswire/ -- S&P Global (NYSE: SPGI) today released a new research report that suggests women could achieve parity with men across senior leadership roles in the U.S. between 2030 and 2037 (Figure 1).

Key Points: 
  • If exponential growth continues, women will have equal representation to men in these roles between 2030 and 2037, according to the research.
  • Extrapolating at current trends, companies in the Russell 3000 would reach gender parity in senior leadership roles between 2030 and 2037.
  • The majority of progress towards gender parity is coming from women taking seats on company boards.
  • During the COVID-19 lockdown in 2020, women in leadership positions grew by only 1.7% rather than the estimated rate of 2.5%.

Cboe Announces Winners of the Options Institute S&P Dow Jones Indices Dispersion Research Grant

Retrieved on: 
Thursday, August 3, 2023
S&P, Cboe Global Markets, University, Mathematics, Center for Financial Studies, Journal of Financial Economics, VIX, Capital market, Fear, Risk management, The Journal of Finance, MBA, Goethe University Frankfurt, Research, Tail, S&P Dow Jones Indices, Assistant, Financial economics, S, Journal, Journal of Monetary Economics, PhD in management, INSEAD, University of Mannheim Business School, Monetary economics, University of Turin, Management, Knowledge, Collegio Carlo Alberto, Frankfurt School, Economics, CBOE, Business mathematics, Pharmaceutical industry, Security (finance)

The Options Institute Research Grant Program aims to support research that helps catalyze the advancement of derivatives usage and financial exchange marketplace structures.

Key Points: 
  • The Options Institute Research Grant Program aims to support research that helps catalyze the advancement of derivatives usage and financial exchange marketplace structures.
  • As the winners of this grant, sponsored by S&P DJI, Dr. Schoenleber and Dr. Vilkov will study the economics behind option-implied factor dispersion.
  • Significantly, this research is expected to complement the planned launch of the Cboe S&P 500 Dispersion Index , a new volatility-related index jointly created by Cboe and S&P DJI.
  • Cboe has been providing best-in-class investor education through the Options Institute, teaching the responsible use of options and trading strategies for more than 35 years.

The new Porsche 911 S/T: the lightest 911 of its generation

Retrieved on: 
Tuesday, August 1, 2023
Acceleration, Porsche Design, Pressure, Heart, Sport, Plaque, MSRP, S/T, Agility, RRP, GT, PCCB, Chronograph, Porsche Rennsport Reunion, Ceramica, GT3, Carbon, Element, Chrono, Movement, Certification, S, Traction, COSC, ZR, CFRP, Disc brake, Electric motor, Road, Telescopic sight, Porsche, Gold

From 1969, Porsche offered a special race version of the 911 S. Internally, these vehicles were called 911 ST.

Key Points: 
  • From 1969, Porsche offered a special race version of the 911 S. Internally, these vehicles were called 911 ST.
  • The new 911 S/T takes up the spirit of the original 911 S (ST) and transfers it to the current model generation of the Porsche 911.
  • Porsche Design is exclusively offering customers of the 911 S/T customers the option to buy a special watch: Chronograph 1 – 911 S/T.
  • The Chronograph 1 – 911 S/T will be available to order from Porsche Centers and Porsche Design Stores, and retails at $13,500 (RRP).

SponsorUnited Celebrates Five Years with Reimagined Logo and Website

Retrieved on: 
Tuesday, August 1, 2023
Sport, S, Intelligence, Online shopping

STAMFORD, Conn., Aug. 1, 2023 /PRNewswire/ -- SponsorUnited, the leading global sports and entertainment intelligence platform tracking 1.1 million sponsorships and endorsements for 250,000 brands and properties across sports, entertainment, media, and talent, today announced the unveiling of its new website and logo, welcoming in the newest iteration of its brand. 

Key Points: 
  • Originating in the sports industry in 2018, SponsorUnited's new logo and brand image encompasses its expansion beyond the sports world, to entertainment, media, and talent.
  • The melding together of the S and the U in the logo is emblematic of the numerous partnerships that have been formed over the years.
  • The reimagined SponsorUnited website boasts a modern, bold, and user-friendly interface and emphasizes engaging content, streamlined browsing and navigation, and enhanced responsiveness across all devices for users.
  • "We are thrilled to announce a momentous milestone in our journey as we unveil our new logo and redesigned website," said Bob Lynch, Founder & CEO, SponsorUnited.

Rhythm Pharmaceuticals Reports Second Quarter 2023 Financial Results and Business Update

Retrieved on: 
Tuesday, August 1, 2023
ENDO, LEPR, Completeness, GCC, Marketing, Food and Drug Administration, Prescription, G&A, Ratio, Bardet–Biedl syndrome, CHI, Data analysis, Acquisition, Caregiver burden, Patient, Investment, Hyperpigmentation, Body mass index, Ageing, R, POMC, MC4R, BMI, FDA, IND, Caregiver, D, Polyphagia, Interest, Publication, Webcast, Obesity, MC1R, Clinical trial, Orphanet Journal of Rare Diseases, Date, Rare, Phase 3, PCSK1, Physician, Food, Pharmaceutical industry, Nursing, Life insurance, Video game, Reinsurance, Cryptocurrency, BBS, Rhythm, S

-- Enrollment ongoing in pivotal Phase 3 trial evaluating setmelanotide in hypothalamic obesity; based on rapid progress, study now expected to be fully enrolled by the end of 2023 --

Key Points: 
  • ET --
    BOSTON, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) pathway diseases, today reported financial results and provided a business update for the second quarter ended June 30, 2023.
  • R&D Expenses: R&D expenses were $33.5 million in the second quarter of 2023, as compared to $31.5 million in the second quarter of 2022.
  • S,G&A Expenses: S,G&A expenses were $30.0 million for the second quarter of 2023, as compared to $22.3 million for the second quarter of 2022.
  • ET today to review its second quarter 2023 financial results and recent business activities.

S&P Global Named Best Artificial Intelligence Technology Provider by WatersTechnology

Retrieved on: 
Monday, July 31, 2023
Acceleration, LLM, Partnership, S&P Global, GAI, Culture, Synthetic media, Magazine, Waters (magazine), S, Acquisition, Investment, Machine learning, Generative, Artificial intelligence, SPGI, Kenshō, AI, NYSE, NERD, Software, Risk management, Sales

NEW YORK, July 31, 2023 /PRNewswire/ -- S&P Global (NYSE: SPGI) announced today Kensho Technologies and the S&P Global Market Intelligence division were named 2023's Best Artificial Intelligence (AI) Technology Provider by Waters Rankings. Voted on by thousands of end users, the Waters Rankings are the only awards program where WatersTechnology's readers determine category winners.

Key Points: 
  • NEW YORK, July 31, 2023 /PRNewswire/ -- S&P Global (NYSE: SPGI) announced today Kensho Technologies and the S&P Global Market Intelligence division were named 2023's Best Artificial Intelligence (AI) Technology Provider by Waters Rankings .
  • "The rapid acceleration of technology innovation at S&P Global has been powered in large part by the acquisition of Kensho Technologies in 2018," said Ewout Steenbergen, Chief Financial Officer of S&P Global and President of Kensho Technologies.
  • It is an honor to be recognized by WatersTechnology as we strive to uphold S&P Global as an innovative and trusted brand that powers global markets."
  • These offerings are made available through S&P Capital IQ Pro and S&P Global Marketplace , both operated by S&P Global Market Intelligence.

Evaxion presents promising results on EVX-B1, an AI-designed vaccine against Staphylococcus aureus 

Retrieved on: 
Monday, July 31, 2023
Infection, Skin infection, Antigen, Gordon Research Conferences, S. aureus, CMC, Global health, S, Doctor of Philosophy, Staphylococcus aureus, Sepsis, Gordon, AI, Research, Bacteria, Immunization, Conference, Disease, Vaccine, Pharmaceutical industry

“I am excited to present the impressive results of EVX-B1 at the Gordon Research Conference.

Key Points: 
  • “I am excited to present the impressive results of EVX-B1 at the Gordon Research Conference.
  • The demonstration of full disease protection and complete bacterial clearance marks a significant advancement in the fight against this widespread and often antibiotic-resistant pathogen.
  • With the many previous unsuccessful attempts to develop an effective S. aureus vaccine, EVX-B1 instills renewed hope in the battle against the bacteria,” said Steven Projan, PhD, Scientific Advisor to Evaxion and poster presenter.
  • The AI technology has enabled the identification of novel S. aureus antigens, paving the way for the development of a vaccine with potential for broad protection against clinically relevant strains.

The euro area bank lending survey – Second quarter of 2023

Retrieved on: 
Wednesday, July 26, 2023
BLS, Climate, European Central Bank, Housing, Table, Bank statement, Pressure, Eurosystem, Website, Policy, NPL, Weakness, Collateralization, Bank, S, History, P, House, Climate change, GDP, Banque du Liban, Acquisition, Investment, Time, Lisa Tauxe, ECB, Risk, European, Logic, Knowledge, Economics Bulletin, Weather, PDF, Credit, Remuneration, Reproduction, Environment, A, SME, PMI, Instrumentation, Real estate, Financial services, Clothing, Security (finance), Landscape maintenance, Life insurance, Risk management, Bookkeeping, Foodservice, Tobacco, Salt, Cabinetry, Renewable energy, Online shopping
Key Points: 

S&P CORELOGIC CASE-SHILLER INDEX REPEATS GAINS IN MAY

Retrieved on: 
Tuesday, July 25, 2023
Housing, Pacific Ocean, History, Composite, S, National Home, Rust Belt, Revenge, City, Cryptocurrency, Dairy

The S&P CoreLogic Case-Shiller U.S. National Home Price NSA Index, covering all nine U.S. census divisions, reported a -0.5% annual decrease in May, down from a loss of -0.1% in the previous month.

Key Points: 
  • The S&P CoreLogic Case-Shiller U.S. National Home Price NSA Index, covering all nine U.S. census divisions, reported a -0.5% annual decrease in May, down from a loss of -0.1% in the previous month.
  • The 10-City Composite showed a decrease of -1.0%, which is a tick up from the -1.1% decrease in the previous month.
  • Chicago, Cleveland, and New York reported the highest year-over-year gains among the 20 cities in May.
  • Granted, the last four months' price gains could be truncated by increases in mortgage rates or by general economic weakness.